BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22955547)

  • 1. Discrimination and anatomical mapping of PET-positive lesions: comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen.
    Kuhn FP; Crook DW; Mader CE; Appenzeller P; von Schulthess GK; Schmid DT
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):44-51. PubMed ID: 22955547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.
    Eiber M; Martinez-Möller A; Souvatzoglou M; Holzapfel K; Pickhard A; Löffelbein D; Santi I; Rummeny EJ; Ziegler S; Schwaiger M; Nekolla SG; Beer AJ
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1691-701. PubMed ID: 21688050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
    Samarin A; Hüllner M; Queiroz MA; Stolzmann P; Burger IA; von Schulthess G; Veit-Haibach P
    Nucl Med Commun; 2015 Dec; 36(12):1165-73. PubMed ID: 26397999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone.
    Paulus DH; Quick HH; Geppert C; Fenchel M; Zhan Y; Hermosillo G; Faul D; Boada F; Friedman KP; Koesters T
    J Nucl Med; 2015 Jul; 56(7):1061-6. PubMed ID: 26025957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
    Blanchet EM; Millo C; Martucci V; Maass-Moreno R; Bluemke DA; Pacak K
    Clin Nucl Med; 2014 Mar; 39(3):243-50. PubMed ID: 24152658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.
    Varoquaux A; Rager O; Poncet A; Delattre BM; Ratib O; Becker CD; Dulguerov P; Dulguerov N; Zaidi H; Becker M
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):462-75. PubMed ID: 24108458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.
    Al-Nabhani KZ; Syed R; Michopoulou S; Alkalbani J; Afaq A; Panagiotidis E; O'Meara C; Groves A; Ell P; Bomanji J
    J Nucl Med; 2014 Jan; 55(1):88-94. PubMed ID: 24337608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
    Stolzmann P; Veit-Haibach P; Chuck N; Rossi C; Frauenfelder T; Alkadhi H; von Schulthess G; Boss A
    Invest Radiol; 2013 May; 48(5):241-6. PubMed ID: 23070096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.
    Souvatzoglou M; Eiber M; Takei T; Fürst S; Maurer T; Gaertner F; Geinitz H; Drzezga A; Ziegler S; Nekolla SG; Rummeny EJ; Schwaiger M; Beer AJ
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1486-99. PubMed ID: 23817684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.
    Beiderwellen K; Grueneisen J; Ruhlmann V; Buderath P; Aktas B; Heusch P; Kraff O; Forsting M; Lauenstein TC; Umutlu L
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):56-65. PubMed ID: 25223420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.
    Hitz S; Habekost C; Fürst S; Delso G; Förster S; Ziegler S; Nekolla SG; Souvatzoglou M; Beer AJ; Grimmer T; Eiber M; Schwaiger M; Drzezga A
    J Nucl Med; 2014 Jun; 55(6):923-31. PubMed ID: 24833495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.
    Cafagna D; Rubini G; Iuele F; Maggialetti N; Notaristefano A; Pinto D; Niccoli-Asabella A; Palmiotti G; Lasciarrea M; Maggialetti A
    Radiol Med; 2012 Mar; 117(2):293-311. PubMed ID: 21744252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.